A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients
University of Pittsburgh
University of Pittsburgh
Maastricht University Medical Center
University Hospital Augsburg
Case Comprehensive Cancer Center
Jules Bordet Institute
Helsinki University Central Hospital
Henry Ford Health System
Centre Hospitalier Universitaire de Nīmes
University of Auckland, New Zealand
Maastricht University Medical Center
Association pour la Recherche Clinique et Immunologique